Verdad Advisers, LP Boston Scientific Corp Transaction History
Verdad Advisers, LP
- $75.2 Million
- Q3 2024
A detailed history of Verdad Advisers, LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Verdad Advisers, LP holds 8,951 shares of BSX stock, worth $849,270. This represents 1.0% of its overall portfolio holdings.
Number of Shares
8,951
Previous 11,080
19.21%
Holding current value
$849,270
Previous $853,000
12.08%
% of portfolio
1.0%
Previous 0.99%
Shares
2 transactions
Others Institutions Holding BSX
# of Institutions
1,543Shares Held
1.19BCall Options Held
6.79MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA131MShares$12.5 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$12 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$5.96 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.59 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$3.11 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $136B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...